Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Value of Options: CBO Health Reform Pre-Scores Draw Yawn From Wall Street

This article was originally published in RPM Report

Executive Summary

The Congressional Budget Office released a book of budget options on over 100 single health reform proposals. Analysts say it’s too early for them to start paying attention. But if recent history provides any lesson, it’s that how CBO scores health reform matters greatly to its overall legislative prospects—and the impact on Wall Street.

You may also be interested in...

Health Care Reform: Plan for Quick Action Dashed By Daschle Withdrawal

The withdrawal of Tom Daschle from consideration as HHS Secretary means there won't be a single focus for health care policy during the upcoming health care reform debate. Can two powerful Democratic legislators and the Obama budget team fill the void?

Prioritizing Health Care: Reform Gains Early Momentum

Health care reform advocates think the stars are aligned for a major push toward universal coverage under President-elect Barack Obama. They aren’t about to let the free-falling economy get in the way.

CBO's Advisors

The Congressional Budget Office will take on heightened importance in 2009 as health care reform becomes a domestic policy priority. Finding meaningful, scorable savings will be imperative in order to move legislation. With that, CBO’s panel of health advisors, a group of outside health care experts who meet periodically to provide guidance to the agency, will take on an increasingly important role.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts